SCIENTIFICALLY
VALIDATED
WITH 5 FDA CLEARANCE

TM-FLOW HARDWARE

Tm-flow Ans Testing Medical Device Is a Highly Comprehensive,
User-friendly, Non-invasive Tool That Focuses on Early Detection
and Follow-up of Complications (Autonomic Nervous System &
Vascular System) by Measuring 8 Health Risk Areas Within the
Body. This Ans Testing Medical Device Effectively Measures the
State of a Patient’s Health by Screening for Hidden Causes of
Disease and Other Chronic Metabolic Diseases Such as Diabetes
and Other Cardiometabolic Risks.

bannecomputerrimage

THE TM-FLOW MEDICAL DEVICE OVERVIEW

Our TM-Flow ANS testing platform is a Medical Device Data System that uses all four LD Technologies to
identify the different Markers that demonstrate the Patient Health Conditions.

landingblockoneimg

Integrated Different Technologies in

the TM Flow Medical Device

The assessment of the Autonomic Nervous System and Vascular system requires several different diagnostic tools, which may be expensive and time-consuming; our TM-Flow device, with its advanced technology, helps physicians to detect ANS and Vascular function through only one exam. Moreover, the integration of these different technologies reduces the time to perform the other measurements.
Sometimes it is difficult for Physicians to differentiate vascular from neuropathic disorders. TM-Flow will help the physician to distinguish between autonomic neuropathy and vascular dysfunction symptoms. As a result, TM-Flow offers physicians a better tool for early detection of chronic disease and more treatment options.

Uses of TM-Flow Medical Device in

a Clinical Setting

This device aims to provide physicians with new technology and a better approach to detect and treat Diabetes and its complications. Diabetes damages the autonomic nerves and micro/macrovascular systems.
Unfortunately, the current laboratory system fails to provide effective treatment results for the early detection of diabetes and its complications. Our ANS device platform offers a better solution to improve a patient’s health conditions.

RST Sanexas

The neoGEN-Series system is a state-of-the-art, technically innovative medical device producing electric cell signaling energy waves (EcST and ESI).

The system successfully treats circulatory issues, acute and chronic pain types, long-term (intractable) pain, and drug-resistant pain. The neoGEN-Series® also offers specific-parameter signaling for efficacious neuromuscular reeducation, muscle strengthening, and relaxation of muscle spasm activity.
The RST-Sanexas neoGEN-Series® medical device is the original and only electric cell signaling device that is used in clinical research, published in multiple medical journals proving the ability to effect nerves and reduce painful symptoms associated with peripheral neuropathy.
More than 30 written therapeutic reports are prepared by written offer covering painful neuropathic conditions and muscular neuromuscular reeducation. RST-Sanexas neoGEN-Series® system is safe, effective, user-friendly, and reimbursed, even by Medicare.

SANEXAS is FDA-approved. Through our Bioenergetics Medical Device Platform, the physician gains immediate access to various patient treatment protocols.

How Sanexas Works

Sanexas uses a technique called electric cell signaling. It is based on the physics of
resonance, which is the electrical signaling between cells. You can think of resonance
like a piano being tuned. The tuner strikes the string, adjusting the energy that vibrates
along the string. This effect is what creates the sound, so adjusting the string will
change the tone.

RST Sanexas uses an advanced technology called electric cell technology. This is
based on the resonance of physics, which is the electrical signaling between the cells.
Electric cell signaling treatment (EST) refers to the administration of multiplexed
signal energy waves delivered via a computer-assisted digital (UHdfg) wave generator
system. Electric cell signaling treatment (EST) mentions the leading multiplex signal
energy waves delivered through the computer-accommodate digital wave
transformer system.

Electric Cell Signaling Reported Clinical Benefits

Applications and Electric Cell Signaling protocols have been subjected to clinical trails. The results have been published in numerous academic, scientific and medical publications and literature.The technologies efficacy is amply demonstrated by these published results and is reinforced anecdotally through the testimonials of thousands of patients.

landingblocksiximgoneleft

CLINICAL BENEFITS

Safe, effective, non-invasive, and user-friendly reimbursable treatment
Minimal potential for side effects, easily avoided
Extremely high patient compliance, outcome, and satisfaction
Substantial reduction in out-bound patient referrals
landingblocksiximgtworight

FDA CLINICAL INDICATIONS

Management and symptomatic relief of chronic (long-term) INTRACTABLE pain
Adjunctive treatment of post-traumatic pain syndromes
Adjunctive treatment in the management of post-surgical pain conditions
Relaxation of muscle spasms
Neuro-muscular reduction
Prevention or retardation of disuse atrophy
Maintaining or increasing range of motion
Increasing local circulation
Immediate post-surgical stimulation of calf muscles to prevent phlebothrombosis